The patient must: Be age 18 or older Have eligible Medicare Part D coverage Be prescribed treatment specifically for weight reduction and maintenance Participate in ongoing nutrition and physical activity intervention Not have already received a GLP-1 through their Part D plan Not be seeking coverage for another Part D-coverable indication, such as type 2 diabetes, moderate-to-severe obstructive sleep apnea, MASH, or cardiovascular risk reduction The patient must also have met one of these criteria when GLP-1 therapy was originally started: BMI 35 BMI 30 plus HFpEF, uncontrolled hypertension despite 2 medications, or CKD stage 3a+ BMI 27 plus prediabetes, prior MI, prior stroke, or symptomatic peripheral artery disease Important: Eligibility is based on BMI at treatment initiation, not necessarily the patients current BMI
Do I need medical experience to take the course
Processed Breakfast Cereals Breakfast sets the tone for the rest of the day, yet many breakfast cereals are surprisingly high in added sugar
The drugs exploded in popularity over the last few years as mounting evidence suggested they could help with weight loss and lower the risk of obesity-related conditions such as high blood pressure, heart attacks or strokes
GLP-1 encourages the development of various advantageous bacteria in the gut, making it easier to produce satiety-related microbial products
After consultation with the respiratory department, vancomycin was added to moxifloxacin, and methylprednisolone (1 mg/kgd) was initiated
